Three-year, $10M Project Created to Research Therapy Resistance in Prostate Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

The project was announced today by Stand Up to Cancer, its scientific partner the American Association for Cancer Research, and the Prostate Cancer Foundation, and is called "Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

Oct
13
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss sample collection challenges associated with tumor sequencing, with a particular focus on somatic variant testing in plasma.